Sodium aminosalicylate use


Release time:

2023-11-30

Sodium aminosalicylate (sodium Aminosalicylate) is a congener of p-aminobenzoic acid (PABA), which inhibits the growth and reproduction of Mycobacterium tuberculosis by competitive inhibition of folic acid synthesis.

Sodium aminosalicylate use

Sodium aminosalicylate (sodium Aminosalicylate) is a congener of p-aminobenzoic acid (PABA), which inhibits the growth and reproduction of Mycobacterium tuberculosis by competitive inhibition of folic acid synthesis. The curative effect is less than that of isoniazid and streptomycin, but it is not easy to produce drug resistance. The combination of these two drugs has a synergistic effect and can delay the occurrence of drug resistance. Oral easy absorption, can penetrate into the tissues and body fluids.

1. It is applicable to pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. Intravenous drip can be used to treat tuberculous meningitis and acute hematogenous disseminated tuberculosis.

2. Can also be used for hyperthyroidism. For patients with hyperthyroidism complicated with tuberculosis, when iodine is ineffective and may affect the operation, short-term use of this drug can create conditions for the operation.